Single answer

Is AEON Biopharma Inc (AEON) a buy or sell?

4starter turns market data into one clear verdict you can act on.

Hold
$0.949
-0.0914 (-8.78%)
Quote updated: 2026-02-12 20:59 UTC
Trend today
-8.78%
Down today
Volume vs avg
30.10%
0.70x under average
Target gap
Not available
Signal updated
Not available
Exchange
AMEX
Sector
Healthcare
Industry
Biotechnology
Add to watchlist

Create a free account to save tickers and track your signals.

Log in to turn on watchlist alerts.

Decision snapshot

Everything you need to act fast, in one glance.

4starter signal
Hold
Not available

Powered by momentum, volatility, and trend inputs.

Analyst target gap
Not available
Volume vs average
30.10%
under average

165,224 vs 236,373 average (0.70x normal).

What is the conclusion?

Right now our advanced algorithms say:

YES

Do analysts agree?

We compare consensus targets with today's price.

No analyst target data available for this ticker.

Company snapshot

A quick overview of the business and its public profile.

AEON Biopharma Inc a biopharmaceutical company focuses on the development botulinum toxins for the treatment of debilitating medical conditions It also develops 900 kDabotulinum toxin complex ABP450 for migraine cervical dystonia and gastroparesis The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma Inc in December 2019 AEON Biopharma Inc was incorporated in 2012 and is headquartered in Newport Beach California

Website: http://www.aeonbiopharma.com

Rates and inflation backdrop

US inflation for September 2025 was 0.31%. Over the last 12 months, the US inflation is 3.02%. The 10-year treasury yield that indicates the future interest level is currently 4.19 and is down -0.16 over the last 30 days.

Inflation sensitivity

AEON Biopharma Inc has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for AEON Biopharma Inc to be high [0.9 out of 1]

Dividend history check

We cannot find any recorded dividends paid in our systems.

Trading liquidity

No, the average daily trading liquidity for AEON Biopharma Inc is $183,896. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

10-year return check

We cannot find data for AEON Biopharma Inc 10 years ago, but if you had invested on Monday 24th of July 2023 when the price was $9.20, you would have made a loss of $-8.38 per share or -91.06%

Why this answer

We combine price momentum, volatility, and trend signals to simplify the decision to one word.

1

Signal engine scans price, trend, and momentum indicators.

2

Targets and sentiment are checked against the live quote.

3

We keep the output simple: buy, sell, or hold.

Analyst consensus

How Wall Street targets compare to today's price.

No analyst target data available for this ticker.

FAQ

Today's 4starter signal is Hold. That means the signal is mixed right now.

Quotes and targets refresh throughout the trading day, with the latest timestamp shown on the page.

It blends momentum, trend, and volatility indicators into a single decision-oriented verdict.